✦ LIBER ✦

Pharmacokinetics of doxorubicin in sarcoma patients

✍ Scribed by J. Robert; N. B. Bui; P. Vrignaud

Publisher: Springer
Year: 1987
Tongue: English
Weight: 391 KB
Volume: 31
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00541297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of low-dose doxorubicin

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

✍ M. Joerger; A. D. R. Huitema; P. L. Meenhorst; J. H. M. Schellens; J. H. Beijnen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 390 KB

Early-phase pharmacokinetics of doxorubi

Early-phase pharmacokinetics of doxorubicin in non-hodgkin lymphoma patients

✍ Jacques Robert; Bernard Hoerni; Patricia Vrignaud; Claude Lagarde 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 454 KB

Factors affecting the pharmacokinetics o

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

✍ Ninh M. La-Beck; Beth A. Zamboni; Alberto Gabizon; Hilary Schmeeda; Michael Aman 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 348 KB

Comparison of the intracellular pharmaco

Comparison of the intracellular pharmacokinetics of doxorubicin and 4′-epi-doxorubicin in patients with acute leukemia

✍ Ulf Tidefelt; Britt Sundman-Engberg; Christer Paul 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 537 KB

Pharmacokinetics and metabolism of iodo-

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

✍ K. Mross; U. Mayer; K. Hamm; K. Burk; D. K. Hossfeld 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 629 KB

The pharmacokinetics of doxorubicin (DOX), iodo-doxorubicin (I-DOX) and their metabolites in plasma has been examined in five patients each receiving 50 mg/m2 of both anthracyclines as a bolus injection. Terminal half-life, mean residence time (MRT), peak plasma concentration Cmax, and area under th

Randomized comparison of doxorubicin and

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas

✍ Ernest C. Borden; David A. Amato; John H. Edmonson; Paul S. Ritch; Masanori Shir 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Two treatment regimens for metastatic soft-tissue sarcomas were compared in a randomized trial in the cooperative group setting. Histopathologic diagnosis was affirmed by pathology reference panel review in 72% of the 347 patients. In 21% of patients, the reference panel affirmed the diagnosis of so